Form 8-K - Current report:
SEC Accession No. 0000950170-24-034693
Filing Date
2024-03-21
Accepted
2024-03-21 16:10:23
Documents
13
Period of Report
2024-03-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crgx-20240321.htm   iXBRL 8-K 40551
2 EX-99.1 crgx-ex99_1.htm EX-99.1 94484
3 GRAPHIC img19376069_0.jpg GRAPHIC 4001
  Complete submission text file 0000950170-24-034693.txt   270117

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crgx-20240321.xsd EX-101.SCH 26947
16 EXTRACTED XBRL INSTANCE DOCUMENT crgx-20240321_htm.xml XML 5114
Mailing Address 1900 ALAMEDA DE LAS PULGAS SUITE 350 SAN MATEO CA 94403
Business Address 1900 ALAMEDA DE LAS PULGAS SUITE 350 SAN MATEO CA 94403 650-379-6143
CARGO Therapeutics, Inc. (Filer) CIK: 0001966494 (see all company filings)

EIN.: 844080422 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41859 | Film No.: 24771427
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)